Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F23%3AW0000003" target="_blank" >RIV/00064211:_____/23:W0000003 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/23:10445975 RIV/00064211:_____/23:W0000052 RIV/00064165:_____/23:10445975
Result on the web
<a href="https://dx.doi.org/10.1007/s00066-022-01983-6" target="_blank" >https://dx.doi.org/10.1007/s00066-022-01983-6</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00066-022-01983-6" target="_blank" >10.1007/s00066-022-01983-6</a>
Alternative languages
Result language
angličtina
Original language name
Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival
Original language description
Purpose To evaluate the effectiveness and toxicity of curative (chemo)radiotherapy in patients with metastatic carcinoma to cervical lymph nodes from an unknown primary. Methods Retrospective study of 90 consecutive patients, treated with curative radiotherapy from 2003 to 2018 (median age 59 years; current/former smokers 76%) was conducted. The distribution of nodal staging was as follows: N1: 12%, N2a: 21%, N2b: 43%, N2c: 10%, N3: 13%. In 62% of patients, neck dissection was performed before radiotherapy. Concomitant chemotherapy was given to 64% of patients. Results The median follow-up of surviving patients was 86 months. The median total radiotherapy dose achieved was 70 Gy. The 5- and 10-year locoregional control were 84% in both cases, while 5- and 10-year distant control were 90% and 89%, respectively. A primary tumor in the head and neck area was detected in only 2 patients. No patient had an initial failure in the pharyngeal axis or contralateral cervical nodes. The 5- and 10-year overall survival were 55% and 42%, respectively. Severe early toxicity occurred in 71%; severe late toxicity in 33% of patients. Multivariate analysis demonstrated N-status (hazard ratio [HR] 2.424; 95% confidence interval [CI] 1.121-5.241; p = 0.024) and comorbidity scores assessed by ACE-27 (Adult Comorbidity Evaluation; HR 3.058; 95% CI 1.489-6.281; p = 0.002) as two independent prognostic factors for overall survival. Conclusion The results of our work study demonstrate the high effectiveness of curative (chemo)radiotherapy on the pharyngeal axis and bilateral cervical nodes with long-term locoregional and distant control in 3/4 of the treated patients. N-status and comorbidity scores were shown as strong prognostic factors influencing overall survival.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
STRAHLENTHERAPIE UND ONKOLOGIE
ISSN
0179-7158
e-ISSN
1439-099X
Volume of the periodical
199
Issue of the periodical within the volume
2
Country of publishing house
DE - GERMANY
Number of pages
11
Pages from-to
149-159
UT code for WoS article
000837929200001
EID of the result in the Scopus database
—